| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 157 |
| 1 | ADALIMUMAB | 153 |
| 2 | METHOTREXATE SODIUM | 153 |
| 3 | DICLOFENAC | 152 |
| 4 | DICLOFENAC SODIUM | 152 |
| 5 | PREDNISONE | 151 |
| 6 | TOCILIZUMAB | 150 |
| 7 | ETANERCEPT | 148 |
| 8 | LEFLUNOMIDE | 148 |
| 9 | HYDROXYCHLOROQUINE SULFATE | 144 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIPROLIDINE HYDROCHLORIDE | 3 | 0.0698 |
| 1 | 200 WET WIPES | 42 | 0.0657 |
| 2 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 19 | 0.0569 |
| 3 | CAFFEINE CITRATE | 67 | 0.0523 |
| 4 | HYDROCORTISONE PROBUTATE | 4 | 0.0519 |
| 5 | HYALURONIDASE (HUMAN RECOMBINANT) | 12 | 0.0397 |
| 6 | DICLOFENAC POTASSIUM TABLETS | 89 | 0.0258 |
| 7 | PSEUDOEPHEDRINE HYDROCHLORIDE | 112 | 0.0203 |
| 8 | PSEUDOEPHEDRINE HCL | 112 | 0.0172 |
| 9 | CORTISONE ACETATE | 128 | 0.0165 |
| # | Drug class | Count |
|---|---|---|
| 0 | CD20-directed Cytolytic Antibody [EPC] | 162 |
| 1 | Corticosteroid [EPC] | 159 |
| 2 | Interleukin-6 Receptor Antagonist [EPC] | 157 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 153 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 150 |
| 5 | Antirheumatic Agent [EPC] | 148 |
| 6 | Vitamin C [EPC] | 146 |
| 7 | Aminosalicylate [EPC] | 145 |
| 8 | Selective T Cell Costimulation Modulator [EPC] | 142 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 141 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 21 | 0.0070 |
| 1 | Methylxanthine [EPC] | 73 | 0.0017 |
| 2 | Antirheumatic Agent [EPC] | 148 | 0.0017 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 157 | 0.0016 |
| 4 | Histamine-1 Receptor Antagonist [EPC] | 59 | 0.0015 |
| 5 | Interleukin-12 Antagonist [EPC] | 117 | 0.0015 |
| 6 | Aminosalicylate [EPC] | 145 | 0.0014 |
| 7 | Selective T Cell Costimulation Modulator [EPC] | 142 | 0.0013 |
| 8 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 19 | 0.0012 |
| 9 | Tetracycline-class Drug [EPC] | 61 | 0.0012 |